Alamar Biosciences, Inc. · Medical Devices

ALMRAlamar Biosciences, Inc.

Reports 2026-11-03 After close · TueReaction day 11-04reported · reaction in progress

Before the print · expectationsfrozen at T-1

No past prints on file yet.

Pricing going in · as of the 10-26 close

−6.8%Move over the last 20 sessionsLast 5 sessions +15.6%
—vs sector (XLV)XLV over the same window —
—Forward P/EConsensus: not available

What the record doesn't tell you

Which way does ALMR go on 11‑03?

  • Model lean for 11-03, and the evidence behind it
  • Move band, P10 – P90
  • Last 8 prints, quarter by quarter
  • Peers that already reported, and how they traded

The print · 8-K and call2026-11-03 · After close

Revenue$34M
est. —
EPS—
est. —
Guidance · FY revenue$121.0M–$123.0Mno comparable consensus

Key figures, the focus-point check, management quotes, the sector read and the grade are in the full view. Start 30-day free trial →

Reactionreaction not yet settled

After-hours move—no read yet
Open / day close— / —
5 days later—day 5 pending

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Alamar Biosciences earnings review: what the record says

Alamar Biosciences (ALMR) reported earnings on Nov 3, 2026, after the close. The company posted revenue of $34M.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.